Stock listing

Revolution Medicines, Inc.

Selected listing: 42Z · GETTEX · EUR · DE

Revolution Medicines, Inc. (gettex:42Z), Health Technology. Latest release Oct 5, 2026: Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309…

42Z:GETTEXEURDEUpdated October 2, 2026

Ticker: gettex:42Z
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: gettex
Currency: EUR

Latest news from Revolution Medicines, Inc.

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer

October 4, 2026

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer

October 5, 2026

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

September 14, 2026

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

September 2, 2026

U.S. FDA Approves Revolution Medicines' RASONQUE (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

August 27, 2026

All Revolution Medicines, Inc. news →

Events

Replays

Revolution Medicines, Inc. (RVMD) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 04:30 PM ET
Watch
Revolution Medicines, Inc. (RVMD) Q1 2026 Earnings Call
Wed, May 06, 2026 · 04:30 PM ET
Watch
Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call
Wed, Feb 25, 2026 · 04:30 PM ET
Watch

Research Revolution Medicines, Inc.

Revolution Medicines, Inc. company profile

View the public company page for Revolution Medicines, Inc. on 6ix.

Revolution Medicines, Inc. news

Read company news and market updates connected to Revolution Medicines, Inc..

Revolution Medicines, Inc. investor events

Find investor webinars, events, and replay context for Revolution Medicines, Inc..